SEARCH

SEARCH BY CITATION

References

  • Albrecht J. and Schousboe A. (2005) Taurine interaction with neurotransmitter receptors in the CNS: an update. Neurochem. Res. 30, 16151621.
  • Alvarez E. O., Beauquis J., Revsin Y., Banzan A. M., Roig P., De Nicola A. F. and Saravia F. (2009) Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav. Brain Res. 198, 224230.
  • Barbeito L. H., Pehar M., Cassina P., Vargas M. R., Peluffo H., Viera L., Estévez A. G. and Beckman J. S. (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 47, 263274.
  • Baydas G., Nedzvetskii V. S., Tuzcu M., Yasar A. and Kirichenko S. V. (2003) Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur. J. Pharmacol. 462, 6771.
  • Biessels G. J., Kamal A., Ramakers G. M., Urban I. J., Spruijt B. M., Erkelens D. W. and Gispen W. H. (1996) Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 45, 12591266.
  • Brands A. M. A., Biessels G. J., De Haan E. H. F., Kappelle L. J. and Kessels R. P. C. (2005) The effects of type 1 diabetes on cognitive performance. Diabetes Care 28, 726735.
  • Bree A. J., Puente E. C., Daphna-Iken D. and Fisher S. J. (2009) Diabetes increases brain damage caused by severe hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 297, E194E201.
  • Burg M. B. and Ferraris J. D. (2008) Intracellular organic osmolytes: function and regulation. J. Biol. Chem. 283, 73097313.
  • Cavassila S., Deval S., Huegen C., Van Ormondt D. and Graveron-Demilly D. (2001) Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed. 14, 278283.
  • Chao C. C., Hu S., Sheng W. S., Bu D., Bukrinsky M. I. and Peterson P. K. (1996) Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16, 276284.
  • Chen J. F., Sonsalla P. K., Pedata F., Melani A., Domenici M. R., Popoli P., Geiger J., Lopes L. V. and De Mendonça A. (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation. Prog. Neurobiol. 83, 310331.
  • Convit A., Wolf O. T., Tarshish C. and De Leon M. J. (2003) Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl Acad. Sci. USA 100, 20192022.
  • Crutcher K. A., Scott S. A., Liang S., Everson W. V. and Weingartner J. (1993) Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer’s disease. J. Neurosci. 13, 25402550.
  • Cunha G. M., Canas P. M., Oliveira C. R. and Cunha R. A. (2006) Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141, 17751781.
  • Cunha R. A. (2005) Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal. 1, 111134.
  • Cunha R. A. (2008) Caffeine, adenosine receptors, memory and Alzheimer disease. Med. Clin. (Barc.) 131, 790795.
  • Del Olmo N., Galarreta M., Bustamante J., Martín del Rio R. and Solís J. M. (2000) Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 39, 4054.
  • Di Leo M. A., Santini S. A., Silveri N. G., Giardina B., Franconi F. and Ghirlanda G. (2004) Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats. Amino Acids 27, 187191.
  • Duarte J. M. N., Oliveira C. R., Ambrosio A. F. and Cunha R. A. (2006) Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats. Neurochem. Int. 48, 144150.
  • Duelli R., Maurer M. H., Staudt R., Heiland S., Duembgen L. and Kuschinsky W. (2000) Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res. 858, 338347.
  • Fanelli C. G., Dence C. S., Markham J., Videen T. O., Paramore D. S., Cryer P. E. and Powers W. J. (1998) Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 47, 14441450.
  • Ferrer I., Blanco R. and Carmona M. (2001) Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat. Brain Res. Mol. Brain Res. 94, 4858.
  • Ferrer I., Blanco R., Cutillas B. and Ambrosio S. (2000) Fas and Fas-L expression in Huntington’s disease and Parkinson’s disease. Neuropathol. Appl. Neurobiol. 26, 424433.
  • Fredholm B. B., Bättig K., Holmén J., Nehlig A. and Zvartau E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83133.
  • García-Espinosa M. A., García-Martín M. L. and Cerdán S. (2003) Role of glial metabolism in diabetic encephalopathy as detected by high resolution 13C NMR. NMR Biomed. 16, 440449.
  • Geissler A., Frund R., Scholmerich J., Feuerbach S. and Zietz B. (2003) Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp. Clin. Endocrinol. Diabetes 111, 421427.
  • Gold S. M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E. and Convit A. (2007) Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50, 711719.
  • Grillo C. A., Piroli G. G., Wood G. E., Reznikov L. R., McEwen B. S. and Reagan L. P. (2005) Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 136, 477486.
  • Gruetter R. and Tkác I. (2000) Field mapping without reference scan using asymmetric echo-planar techniques. Magn. Reson. Med. 43, 319323.
  • Gruetter R., Ugurbil K. and Seaquist E. R. (1998) Steady-state cerebral glucose concentrations and transport in the human brain. J. Neurochem. 70, 397408.
  • Hada J., Kaku T., Morimoto K., Hayashi Y. and Nagai K. (1998) Activation of adenosine A2 receptors enhances high K+-evoked taurine release from rat hippocampus: a microdialysis study. Amino Acids 15, 4352.
  • Hammer J., Qu H., Håberg A. and Sonnewald U. (2001) In vivo effects of adenosine A2 receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo13C MR spectroscopy. J. Neurochem. 79, 885892.
  • Honig L. S., Chambliss D. D., Bigio E. H., Carroll S. L. and Elliott J. L. (2000) Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 55, 10821088.
  • Huber J. D., VanGilder R. L. and Houser K. A. (2006) Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am. J. Physiol. Heart Circ. Physiol. 291, H2660H2668.
  • Kreis R. and Ross B. D. (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184, 123130.
  • Lauderback C. M., Hackett J. M., Huang F. F., Keller J. N., Szweda L. I., Markesbery W. R. and Butterfield D. A. (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer’s disease brain: the role of Aβ1-42. J. Neurochem. 78, 413416.
  • Lei H. and Gruetter R. (2006) Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: a localized 13C NMR study. J. Neurochem. 99, 260268.
  • Li F., Abatan O. I., Kim H., Burnett D., Larkin D., Obrosova I. G. and Stevens M. J. (2006) Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol. Dis. 22, 669676.
  • Lien Y. H., Shapiro J. I. and Chan L. (1990) Effects of hypernatremia on organic brain osmoles. J. Clin. Invest. 85, 14271435.
  • Lien Y. H., Shapiro J. I. and Chan L. (1991) Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J. Clin. Invest. 88, 303309.
  • Malone J. I., Hanna S. K. and Saporta S. (2006) Hyperglycemic brain injury in the rat. Brain Res. 1076, 915.
  • McCall A. L., Millington W. R. and Wurtman R. J. (1982) Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc. Natl Acad. Sci. USA 79, 54065410.
  • Mlynárik V., Gambarota G., Frenkel H. and Gruetter R. (2006) Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn. Reson. Med. 56, 965970.
  • Pelligrino D. A., LaManna J. C., Duckrow R. B., Bryan R. M. Jr and Harik S. I. (1992) Hyperglycemia and blood-brain barrier glucose transport. J. Cereb. Blood Flow Metab. 12, 887899.
  • Pop-Busui R., Sullivan K. A., Van Huysen C., Bayer L., Cao X., Towns R. and Stevens M. J. (2001) Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Exp. Neurol. 168, 259272.
  • Provencher S. W. (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30, 672679.
  • Rose S. J., Bushi M., Nagra I. and Davies W. E. (2000) Taurine fluxes in insulin dependent diabetes mellitus and rehydration in streptozotocin treated rats. Adv. Exp. Med. Biol. 483, 497501.
  • Saravia F. E., Revsin Y., Gonzalez Deniselle M. C., Gonzalez S. L., Roig P., Lima A., Homo-Delarche F. and De Nicola A. F. (2002) Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res. 957, 345353.
  • Seaquist E. R., Tkac I., Damberg G., Thomas W. and Gruetter R. (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54, 10081013.
  • Shockley R. P. and LaManna J. C. (1988) Determination of rat cerebral cortical blood volume changes by capillary mean transit time analysis during hypoxia, hypercapnia and hyperventilation. Brain Res. 454, 170178.
  • Silva C. G., Porciúncula L. O., Canas P. M., Oliveira C. R. and Cunha R. A. (2007) Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. Neurobiol. Dis. 27, 182189.
  • Simpson I. A., Appel N. M., Hokari M., Oki J., Holman G. D., Maher F., Koehler-Stec E. M., Vannucci S. J. and Smith Q. R. (1999) Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J. Neurochem. 72, 238247.
  • Simpson I. A., Carruthers A. and Vannucci S. J. (2007) Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 27, 17661791.
  • Takahashi R. N., Pamplona F. A. and Prediger R. D. (2008) Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front. Biosci. 13, 26142632.
  • Tomlinson D. R. and Gardiner N. J. (2008) Glucose neurotoxicity. Nat. Rev. Neurosci. 9, 3645.
  • Trachtman H., Futterweit S. and Sturman J. A. (1992) Cerebral taurine transport is increased during streptozocin-induced diabetes in rats. Diabetes 41, 11301140.
  • Van Dam R. M. and Hu F. B. (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294, 97104.
  • Van Der Graaf M., Janssen S. W., Van Asten J. J., Hermus A. R., Sweep C. G., Pikkemaat J. A., Martens G. J. and Heerschap A. (2004) Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats assessed by in vivo1H magnetic resonance spectroscopy. NMR Biomed. 17, 405410.
  • Wurm A., Iandiev I., Hollborn M., Wiedemann P., Reichenbach A., Zimmermann H., Bringmann A. and Pannicke T. (2008) Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina. Exp. Eye Res. 87, 385393.